About SLU-PP-332
SLU-PP-332 is a synthetic small-molecule compound studied for its activity as an estrogen-related receptor alpha (ERR?) agonist in metabolic research. Supplied for laboratory investigations into nuclear-receptor signaling, mitochondrial biogenesis pathway markers, and oxidative-metabolism mechanisms. Each batch is verified for identity and purity using appropriate analytical methods; refer to the Certificate of Analysis for details. Supplied as: Powder (research compound) Purity: >98 Storage: Room temperature (cool, dry), protect from light Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.
Recent research on SLU-PP-332: In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.
Read Full Study on PubMedAnalysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.
Recent research on SLU-PP-332: Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.
Read Full Study on PubMedAdditional Studies
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.
Recent research on SLU-PP-332: An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.
Read on PubMedTargeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.
Recent research on SLU-PP-332: Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.
Read on PubMedA Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Recent research on SLU-PP-332: A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Read on PubMedNovel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
Recent research on SLU-PP-332: Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
Read on PubMedRelated Research
Purchase SLU-PP-332 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.